172 related articles for article (PubMed ID: 12165373)
1. Neuronal calcium-binding proteins and schizophrenia.
Eyles DW; McGrath JJ; Reynolds GP
Schizophr Res; 2002 Sep; 57(1):27-34. PubMed ID: 12165373
[TBL] [Abstract][Full Text] [Related]
2. Selective deficits in prefrontal cortical GABAergic neurons in schizophrenia defined by the presence of calcium-binding proteins.
Beasley CL; Zhang ZJ; Patten I; Reynolds GP
Biol Psychiatry; 2002 Oct; 52(7):708-15. PubMed ID: 12372661
[TBL] [Abstract][Full Text] [Related]
3. Neurons expressing calcium-binding proteins in the prefrontal cortex in schizophrenia.
Tooney PA; Chahl LA
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Mar; 28(2):273-8. PubMed ID: 14751422
[TBL] [Abstract][Full Text] [Related]
4. Changes in density of calcium-binding-protein-immunoreactive GABAergic neurons in prefrontal cortex in schizophrenia and bipolar disorder.
Sakai T; Oshima A; Nozaki Y; Ida I; Haga C; Akiyama H; Nakazato Y; Mikuni M
Neuropathology; 2008 Apr; 28(2):143-50. PubMed ID: 18069969
[TBL] [Abstract][Full Text] [Related]
5. D2 and D4 dopamine receptor mRNA distribution in pyramidal neurons and GABAergic subpopulations in monkey prefrontal cortex: implications for schizophrenia treatment.
de Almeida J; Mengod G
Neuroscience; 2010 Nov; 170(4):1133-9. PubMed ID: 20727949
[TBL] [Abstract][Full Text] [Related]
6. The density and spatial distribution of GABAergic neurons, labelled using calcium binding proteins, in the anterior cingulate cortex in major depressive disorder, bipolar disorder, and schizophrenia.
Cotter D; Landau S; Beasley C; Stevenson R; Chana G; MacMillan L; Everall I
Biol Psychiatry; 2002 Mar; 51(5):377-86. PubMed ID: 11904132
[TBL] [Abstract][Full Text] [Related]
7. Neurochemical correlates of cortical GABAergic deficits in schizophrenia: selective losses of calcium binding protein immunoreactivity.
Reynolds GP; Zhang ZJ; Beasley CL
Brain Res Bull; 2001 Jul; 55(5):579-84. PubMed ID: 11576754
[TBL] [Abstract][Full Text] [Related]
8. Anomalous inhibitory circuits in cortical tubers of human tuberous sclerosis complex associated with refractory epilepsy: aberrant expression of parvalbumin and calbindin-D28k in dysplastic cortex.
Valencia I; Legido A; Yelin K; Khurana D; Kothare SV; Katsetos CD
J Child Neurol; 2006 Dec; 21(12):1058-63. PubMed ID: 17156698
[TBL] [Abstract][Full Text] [Related]
9. GABAergic neurons immunoreactive for calcium binding proteins are reduced in the prefrontal cortex in major depression.
Rajkowska G; O'Dwyer G; Teleki Z; Stockmeier CA; Miguel-Hidalgo JJ
Neuropsychopharmacology; 2007 Feb; 32(2):471-82. PubMed ID: 17063153
[TBL] [Abstract][Full Text] [Related]
10. Altered Markers of Cortical γ-Aminobutyric Acid Neuronal Activity in Schizophrenia: Role of the NARP Gene.
Kimoto S; Zaki MM; Bazmi HH; Lewis DA
JAMA Psychiatry; 2015 Aug; 72(8):747-56. PubMed ID: 26038830
[TBL] [Abstract][Full Text] [Related]
11. A rodent model of schizophrenia derived from postmortem studies.
Berretta S; Gisabella B; Benes FM
Behav Brain Res; 2009 Dec; 204(2):363-8. PubMed ID: 19539659
[TBL] [Abstract][Full Text] [Related]
12. Cortical and brainstem neurons containing calcium-binding proteins in a murine model of Duchenne's muscular dystrophy: selective changes in the sensorimotor cortex.
Carretta D; Santarelli M; Vanni D; Ciabatti S; Sbriccoli A; Pinto F; Minciacchi D
J Comp Neurol; 2003 Jan; 456(1):48-59. PubMed ID: 12508313
[TBL] [Abstract][Full Text] [Related]
13. Density of glutamic acid decarboxylase 67 messenger RNA-containing neurons that express the N-methyl-D-aspartate receptor subunit NR2A in the anterior cingulate cortex in schizophrenia and bipolar disorder.
Woo TU; Walsh JP; Benes FM
Arch Gen Psychiatry; 2004 Jul; 61(7):649-57. PubMed ID: 15237077
[TBL] [Abstract][Full Text] [Related]
14. Neurodegenerative and morphogenic changes in a mouse model of temporal lobe epilepsy do not depend on the expression of the calcium-binding proteins parvalbumin, calbindin, or calretinin.
Bouilleret V; Schwaller B; Schurmans S; Celio MR; Fritschy JM
Neuroscience; 2000; 97(1):47-58. PubMed ID: 10771338
[TBL] [Abstract][Full Text] [Related]
15. The Fragile Brain: Stress Vulnerability, Negative Affect and GABAergic Neurocircuits in Psychosis.
Taylor SF; Grove TB; Ellingrod VL; Tso IF
Schizophr Bull; 2019 Oct; 45(6):1170-1183. PubMed ID: 31150555
[TBL] [Abstract][Full Text] [Related]
16. Calcium binding proteins and neuropeptides as molecular markers of GABAergic interneurons in the cat visual cortex.
Demeulemeester H; Arckens L; Vandesande F; Orban GA; Heizmann CW; Pochet R
Exp Brain Res; 1991; 84(3):538-44. PubMed ID: 1864325
[TBL] [Abstract][Full Text] [Related]
17. The immunohistochemical examination of GABAergic interneuron markers in the dorsolateral prefrontal cortex of patients with late-life depression.
Khundakar A; Morris C; Thomas AJ
Int Psychogeriatr; 2011 May; 23(4):644-53. PubMed ID: 21044398
[TBL] [Abstract][Full Text] [Related]
18. Increases in the density of parvalbumin-immunoreactive neurons in anterior cingulate cortex of amphetamine-withdrawn rats: evidence for corticotropin-releasing factor in sustained elevation.
Mohila CA; Onn SP
Cereb Cortex; 2005 Mar; 15(3):262-74. PubMed ID: 15238432
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical evaluation of the GABAergic neuronal system in the prefrontal cortex of a DISC1 knockout mouse model of schizophrenia.
Umeda K; Iritani S; Fujishiro H; Sekiguchi H; Torii Y; Habuchi C; Kuroda K; Kaibuchi K; Ozaki N
Synapse; 2016 Dec; 70(12):508-518. PubMed ID: 27421906
[TBL] [Abstract][Full Text] [Related]
20. Calcium binding protein markers of GABA deficits in schizophrenia--postmortem studies and animal models.
Reynolds GP; Abdul-Monim Z; Neill JC; Zhang ZJ
Neurotox Res; 2004; 6(1):57-61. PubMed ID: 15184106
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
